Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369259
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-04-12
Brief Title:
Open-label Phase 2 Study of Avutometinib RAFMEK Clamp in Combination With Defactinib FAK Inhibitor and Cetuximab in Patients With Unresectable Anti-EGFR-Refractory Advanced Colorectal Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-12
First Submit QC Date:
April 12 2024
Study First Post Date:
2024-04-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-03
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL